Arista Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,380
Closed -$446K 274
2025
Q3
$446K Hold
1,380
0.06% 159
2025
Q2
$537K Buy
+1,380
New +$555K 0.07% 140
2024
Q3
Sell
-858
Closed -$465K 72
2024
Q2
$465K Buy
+858
New +$454K 0.12% 42
2024
Q1
Sell
-858
Closed -$405K 39
2023
Q4
$405K Hold
858
0.15% 33
2023
Q3
$374K Hold
858
0.15% 36
2023
Q2
$381K Hold
858
0.16% 37
2023
Q1
$395K Hold
858
0.22% 40
2022
Q4
$440K Buy
+858
New +$436K 0.28% 34

Other funds holding ELV

Arista Wealth Management's ELV Position: Q4 2025 in Review

Arista Wealth Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,380 shares — an estimated $446K sold.

Arista Wealth Management first reported a position in ELV in Q4 2022 and held it in 8 quarters. The position peaked at $537K in Q2 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Arista Wealth Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Arista Wealth Management sold 1,380 Elevance Health shares in Q4 2025, an estimated $446K.
  • Arista Wealth Management first reported a position in Elevance Health in Q4 2022 and held it in 8 quarters.
  • Arista Wealth Management's Elevance Health position peaked at $537K in Q2 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Arista Wealth Management's 13F filing for Q4 2025, filed 9 Feb 2026.